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 Discontinuation of vasopressors or inotropes is a common pre-condition for 
spontaneous breathing trials or extubation in U.S. clinical trials and guidelines.1-4 A 
contrary view is that such a delay increases patients’ risks for the complications of 
endotracheal intubation and mechanical ventilation5 and may mandate additional 
intensive care unit (ICU) time, decreasing throughput and effective ICU capacity.6  
 Glasgow Royal Infirmary ICU (GRI) extubates select patients whilst on 
vasopressors/inotropes (‘vasoactive infusions’), but the safety of this procedure has 
never been formally evaluated. We asked: “Among intubated patients who ever receive 
vasoactive infusions, are extubations attempted whilst patients are still on vasoactive 
infusions associated with different ICU mortality (primary outcome) than extubations 
attempted after the infusions have been stopped?” Secondary outcomes included 
reintubation, hospital mortality, and ICU and hospital lengths of stay. 
 GRI is a 20 bed mixed medical/surgical ICU with tertiary referrals for burn, upper 
gastrointestinal, and pancreatic care. It does not have cardiothoracic services on site 
and does not routinely admit elective surgical patients with an uneventful intraoperative 
course. Neither an extubation protocol nor formal SBTs are routinely employed. Clinical 
practice is to extubate patients—at the attending physician’s discretion—who have 
minimal ventilatory and oxygen support, an adequate cough, and ideally are able to 
participate with physiotherapy. 
This retrospective study included all patients intubated from January 2007 to 
February 2017, who received a vasoactive infusion while intubated. Each patient’s first 
extubation attempt was analyzed, as patients who have previously failed an extubation 
are managed in different ways. We did not include readmissions in the same hospital 
episode and the ICU death was defined as death arising from the index ICU admission. 
Patients receiving 0 to 0.1 mg/hr of noradrenaline, adrenaline, metaraminol, or 
dobutamine at the time of their extubation were excluded (n=43) as this is a marginal 
dose. Also excluded were those who: died prior to a first extubation attempt; self-
extubated (n=4); and were extubated explicitly onto a palliative care pathway (n=6). De-
identified data were extracted from operational electronic data systems. Data were 
analyzed in R (R Core Team 2017, Version 3.4.3). Continuous variables were analyzed 
using the Mann-Whitney U tests, categorical variables were compared using chi-square 
tests, analyses at risk of censoring (e.g., reintubation rates) due to ICU mortality were 
performed with censored time to event analysis, and multivariable logistic regression 
used for adjustment for ICU admission characteristics.7 
Ethics approval was formally deemed unnecessary for these de-identified data.   
 There were 4008 intubated ICU patients in the study period, of whom 1319 met 
inclusion criteria; 43 were excluded as they were extubated on marginal doses of 
vasoactive agents, 4 because they self-extubated, and 6 because they were extubated 
directly for palliative care. The primary study cohort thus consisted of 1266 patients: 280 
patients (21%) extubated on vasoactive infusions and 986 extubated after 
discontinuation. Patients extubated on vasoactive medications were somewhat less ill at 
presentation (APACHE II 19 vs. 21, p=0.007). 
There was no difference in ICU mortality between the two groups (n=18 deaths 
(6.4%) on vasoactive medications vs. n=80 (8.1%) off, p=0.42). There was no difference 
in the in-ICU re-intubation rate between the 2 groups (n=30 reintubations (10.7%) on 
vasoactive infusions vs. n=120 (12.2%), p=0.58. Patients extubated on vasoactive 
infusions had a slightly shorter ICU stay after extubation  (2 days vs. 2.2 days, p=0.049), 
but a shorter overall ICU LOS (5 days vs. 9 days, p<0.001) and duration of mechanical 
ventilation (2 days vs. 6 days, p<0.001). (Table 1).  
In-hospital mortality after first extubation through day 90 is shown in Figure 1. 
There was no statistically significant difference in-hospital mortality in the patients 
extubated on, as opposed to off vasoactive medications (total in-hospital mortality: n=51 
(18.2%) vs n=137 (13.9%), p=0.09), with a median time from extubation to death of 9.6 
days (2.4-22.4 days); this was longer among decedents extubated on vasoactive 
medications (15.5 days (7.5, 31) vs 9.5 days (1.2, 18.5), p=0.005). 
After multivariable adjustment for differences between the groups at ICU 
admission—include age, APACHE II, dialysis during ICU stay, and ICU diagnosis — 
there is no significance difference for any of the outcomes between those extubated on 
vasoactive agents and those extubated not on vasoactive agents (hospital mortality 
adjusted p value = 0.0805, unit mortality adjusted p-value = 0.332 and reintubation 
adjusted p-value = 0.8383). 
In summary, in this large single center study, 21% of intubated patients who 
received infusions of vasoactive infusions while mechanically ventilated were extubated 
for the first time whilst still receiving them. Coincident with their earlier extubation, their 
ICU length of stay was shorter without an increase in ICU mortality, hospital mortality or 
reintubation rate, suggesting that this can be safe practice. Rates of reintubation were 
similar to published U.S. rates among comparable emergent surgical (10.7%), medical 
(10.7%), and trauma (13.5%) patients.8 
These single center data suggest that current U.S. clinical trial practice and 
guidelines may be unnecessarily conservative. In the modern era of lung protective 
ventilation and reduced sedation, patients may be otherwise ready to extubate prior to 
full return of hemodynamic stability. Contrary to current practice in recent and ongoing 
U.S. clinical trials, these data suggest it may be safe to do so in select situations. There 
are few data on how widespread this practice is. 
Limitations of this single center observational data include the absence of 
random assignment to extubation protocol and the absence of detailed physiologic 
information matched on day of possible extubation. 
These data do not prove that extubation on vasoactive agents is always as safe 
as other extubations. Instead, they call for the development of protocols for identifying 
patients who can be safely extubated despite continued vasoactive infusions—thereby 
speeding ICU recovery—and the rigorous testing of such protocols in randomized 
evaluations. 
 
  
Figure 1: Kaplan-Meier Curve showing time to in-hospital mortality, censored at 
hospital discharge, with 95% confidence intervals. 
 
 
 
  
Table 1: Comparison of first time extubation trends within the GRI population. All 
length of stay variables are calculated in hours and then transformed into days, allowing 
medians to two significant figures to be calculated. For continuous variables, median 
plus (interquartile range) is presented. 
Variable 
Extubated on 
vasopressors 
(n=280) 
Extubated off 
vasopressors 
(n=986) 
p-value 
Age 62 (49-73) 59 (47-69) 0.004 
Male Gender 148 (52.9%) 568 (57.6%) 0.178 
Apache II 19 (14-25) 21 (16-26) 0.007 
Renal Replacement 37 (12.4%) 198 (18.9%) 0.011 
Specialty 
  
< 0.001 
  General surgery 149 (53.2%) 374 (37.9%) 
 
  General medicine 61 (21.8%) 362 (36.7%) 
 
  Plastic/Burn surgery 26 (9.3%) 79 (8.0%) 
 
  Other 13 (4.6%) 49 (5%) 
 
  Orthopedic surgery 8 (2.9%) 45 (4.6%) 
 
  Obstetrics 7 (2.5%) 13 (1.3%)  
  Urology 7 (2.5%) 17 (1.7%)  
  Geriatric medicine 5 (1.8%) 21 (2.1%) 
 
  Gastroenterology 4 (1.4%) 26 (2.6%) 
 
Comorbidities   0.658 
  0 1 (0.4%) 9 (0.9%) 
 
  1 218 (77.9%) 758 (76.9%) 
 
  2 47 (16.8%) 156 (15.8%) 
 
  3+ 14 (5%) 63 (6.4%) 
 
Total ICU LOS pre-extubation (days) 0.9 (0.5-1.8) 4.5 (1.8-10) < 0.001 
ICU LOS to first reintubation (days) 0.5 (0.2-1.1) 0.6 (0.2-1.3) 0.699 
Total Length of Ventilation (days) 2 (1-4) 6 (3-12) < 0.001 
ICU LOS after extubation until ICU discharge 
(days) 
2 (1-4.6) 2.2 (1.1-5.2) 0.049 
Total ICU LOS (days) 5 (3-9) 9 (4-17) < 0.001 
LOS after ICU discharge  14.3 (5.3-30.4) 12.2 (4.3-26.6) 0.032 
    
Time from extubation to death (days) 15.5 (7.5-31.1) 9.5 (1.2-18.5) 0.005 
Reintubation Rate 30 (10.7%) 120 (12.2%) 0.575 
ICU Mortality on index admission 18 (6.4%) 80 (8.1%) 0.419 
Total In-Hospital Mortality 51 (18.2%) 137 (13.9%) 0.09 
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